Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare BATS:ENAVNASDAQ:NITEBATS:SNAVNASDAQ:VMOT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeENAVMohr Sector Navigator ETF$31.02-0.3%$29.29$0.00▼$0.00$24.04M0.93N/A5,085 shsNITENightstar Therapeutics$28.86-2.9%$25.41$9.59▼$29.55$968.13M2.84185,808 shs2,889 shsSNAVMohr Sector Nav ETF$31.39+3.4%$29.40$26.31▼$32.21$23.96M0.9215,121 shs14,695 shsVMOTAlpha Architect Value Momentum Trend ETF$26.40+1.0%$24.61$23.03▼$27.77$21.92M0.481,645 shs255 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceENAVMohr Sector Navigator ETF-0.06%+1.27%+4.68%+2.76%+6.27%NITENightstar Therapeutics-0.33%-0.64%+9.33%+7.81%+17.03%SNAVMohr Sector Nav ETF-0.06%+1.14%+5.85%+2.03%+6.34%VMOTAlpha Architect Value Momentum Trend ETF0.00%+0.84%+4.62%+7.50%+3.95%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationENAVMohr Sector Navigator ETFN/AN/AN/AN/AN/AN/AN/AN/ANITENightstar TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ASNAVMohr Sector Nav ETFN/AN/AN/AN/AN/AN/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceENAVMohr Sector Navigator ETF 0.00N/AN/AN/ANITENightstar Therapeutics 0.00N/AN/AN/ASNAVMohr Sector Nav ETF 0.00N/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETF 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookENAVMohr Sector Navigator ETFN/AN/AN/AN/AN/AN/ANITENightstar TherapeuticsN/AN/AN/AN/A$5.89 per shareN/ASNAVMohr Sector Nav ETFN/AN/AN/AN/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateENAVMohr Sector Navigator ETFN/AN/A19.27∞N/AN/AN/AN/AN/ANITENightstar Therapeutics-$36.86M-$1.26N/AN/AN/AN/A-30.89%-27.65%N/ASNAVMohr Sector Nav ETFN/AN/A19.27∞N/AN/AN/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETFN/AN/A13.56∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthENAVMohr Sector Navigator ETF$0.280.90%N/AN/AN/ANITENightstar TherapeuticsN/AN/AN/AN/AN/ASNAVMohr Sector Nav ETF$0.280.89%N/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETF$0.642.42%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioENAVMohr Sector Navigator ETFN/AN/AN/ANITENightstar TherapeuticsN/A8.548.54SNAVMohr Sector Nav ETFN/AN/AN/AVMOTAlpha Architect Value Momentum Trend ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipENAVMohr Sector Navigator ETFN/ANITENightstar Therapeutics32.83%SNAVMohr Sector Nav ETFN/AVMOTAlpha Architect Value Momentum Trend ETFN/AInsider OwnershipCompanyInsider OwnershipENAVMohr Sector Navigator ETFN/ANITENightstar TherapeuticsN/ASNAVMohr Sector Nav ETFN/AVMOTAlpha Architect Value Momentum Trend ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableENAVMohr Sector Navigator ETFN/A775,000N/ANot OptionableNITENightstar Therapeutics4733.54 millionN/ANot OptionableSNAVMohr Sector Nav ETFN/A775,000N/ANot OptionableVMOTAlpha Architect Value Momentum Trend ETFN/A830,000N/AN/AENAV, VMOT, SNAV, and NITE HeadlinesRecent News About These CompaniesTime for Global Equities ETFs?September 20, 2024 | zacks.comENAV, VMOT, SNAV, and NITE Company DescriptionsMohr Sector Navigator ETF BATS:ENAV$31.02 -0.10 (-0.32%) As of 06/5/2025There is no description available for this ETF.Nightstar Therapeutics NASDAQ:NITENightstar Therapeutics plc, a clinical-stage gene therapy company, focuses on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases in the United Kingdom. The company's lead product candidate is NSR-REP1, a candidate that is in phase 3 clinical development for the treatment of patients with choroideremia. It is also developing NSR-RPGR, a candidate that is in Phase 1/2 clinical trials for the treatment of patients with X-linked retinitis pigmentosa, an inherited X-linked recessive retinal disease; and NSR-BEST1, a candidate that is in preclinical development stage for the treatment of best vitelliform macular dystrophy. In addition, the company is developing NSR-ABCA4, a candidate that is in preclinical development stage for the treatment of Stargardt disease. The company was founded in 2013 and is headquartered in London, the United Kingdom.Mohr Sector Nav ETF BATS:SNAV$31.39 +1.02 (+3.35%) As of 11:06 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.The Mohr Sector Nav ETF (SNAV) is an exchange-traded fund that is based on the S&P 500 index. The fund is an actively managed fund that tactically invests across US market sectors. SNAV was launched on Jan 11, 2023 and is managed by Mohr Funds.Alpha Architect Value Momentum Trend ETF NASDAQ:VMOT$26.40 +0.26 (+1.00%) As of 06/2/2025The Alpha Architect Value Momentum Trend ETF (VMOT) is an exchange-traded fund that mostly invests in total market equity. The fund is an active, equal-risk-weighted portfolio of value- and momentum-oriented ETFs. The fund can fully hedge its equity exposure in down-trending markets. VMOT was launched on May 3, 2017 and is issued by Alpha Architect. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Market’s Silent Warning: What Bonds and Gold Reveal AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio? Why Visa's Innovation Engine Keeps It a Top Portfolio Pick Is Meta Plotting a Stablecoin Comeback Years After Libra's Flop? NVIDIA Regains Top Spot; FOMO Is Why It Will Continue to Rise Robinhood Stock Keeps Giving Investors Reasons To Buy Hims & Hers Stock: Buy the Dip or Wait It Out? Boeing: Analyst Upgrades & Order Boom Signal Clearer Skies Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
